PubMed

Endostatin and anastellin inhibit distinct aspects of the angiogenic process.

Neskey DM, Ambesi A, Pumiglia KM, McKeown-Longo PJ.

J Exp Clin Cancer Res. 2008 Nov 4;27:61.PMID: 18983664 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Anastellin, a fragment of the first type III repeat of fibronectin, inhibits extracellular signal-regulated kinase and causes G(1) arrest in human microvessel endothelial cells.

Ambesi A, Klein RM, Pumiglia KM, McKeown-Longo PJ.

Cancer Res. 2005 Jan 1;65(1):148-56.PMID: 15665290 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.

Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4766-71. Epub 2003 Apr 7.PMID: 12682293 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.

Morbidelli L, Donnini S, Chillemi F, Giachetti A, Ziche M.

Clin Cancer Res. 2003 Nov 1;9(14):5358-69.PMID: 14614021 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.

Heljasvaara R, Nyberg P, Luostarinen J, Parikka M, Heikkilä P, Rehn M, Sorsa T, Salo T, Pihlajaniemi T.

Exp Cell Res. 2005 Jul 15;307(2):292-304.PMID: 15950618 [PubMed - indexed for MEDLINE]Related citations

Simulation of tumor-induced angiogenesis and its response to anti-angiogenic drug treatment: mode of drug delivery and clearance rate dependencies.

Tee D, DiStefano J 3rd.

J Cancer Res Clin Oncol. 2004 Jan;130(1):15-24. Epub 2003 Oct 28.PMID: 14586644 [PubMed - indexed for MEDLINE]Related citations

Effect of human recombinant Endostatin protein on human angiogenesis.

Jung SP, Siegrist B, Hornick CA, Wang YZ, Wade MR, Anthony CT, Woltering EA.

Angiogenesis. 2002;5(1-2):111-8.PMID: 12549868 [PubMed - indexed for MEDLINE]Related citations

AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.

Mallery SR, Morse MA, Wilson RF, Pei P, Ness GM, Bradburn JE, Renner RJ, Schuller DE, Robertson FM.

J Cell Biochem. 2003 May 1;89(1):133-43.PMID: 12682914 [PubMed - indexed for MEDLINE]Related citations

The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix.

Delaney CE, Weagant BT, Addison CL.

Exp Cell Res. 2006 Aug 1;312(13):2476-89. Epub 2006 Apr 22.PMID: 16725139 [PubMed - indexed for MEDLINE]Related citations

Endostatin signaling and regulation of endothelial cell-matrix interactions.

Wickström SA, Alitalo K, Keski-Oja J.

Adv Cancer Res. 2005;94:197-229. Review.PMID: 16096002 [PubMed - indexed for MEDLINE]Related citations

Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage.

Pufe T, Petersen WJ, Miosge N, Goldring MB, Mentlein R, Varoga DJ, Tillmann BN.

Matrix Biol. 2004 Aug;23(5):267-76.PMID: 15464359 [PubMed - indexed for MEDLINE]Related citations

Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice.

Li Q, Olsen BR.

Am J Pathol. 2004 Aug;165(2):415-24.PMID: 15277216 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.

Jin X, Bookstein R, Wills K, Avanzini J, Tsai V, LaFace D, Terracina G, Shi B, Nielsen LL.

Cancer Gene Ther. 2001 Dec;8(12):982-9.PMID: 11781661 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

The response of VEGF-stimulated endothelial cells to angiostatic molecules is substrate-dependent.

Addison CL, Nör JE, Zhao H, Linn SA, Polverini PJ, Delaney CE.

BMC Cell Biol. 2005 Oct 31;6:38.PMID: 16262896 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model.

Tanabe K, Maeshima Y, Ichinose K, Kitayama H, Takazawa Y, Hirokoshi K, Kinomura M, Sugiyama H, Makino H.

Kidney Int. 2007 Feb;71(3):227-38. Epub 2006 Dec 27.PMID: 17191085 [PubMed - indexed for MEDLINE]Related citations

Opposite effects of endostatin on different endothelial cells.

Schmidt A, Addicks K, Bloch W.

Cancer Biol Ther. 2004 Nov;3(11):1162-6; discussion 1167-8. Epub 2004 Nov 9.PMID: 15640622 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.

Cho H, Kim WJ, Lee YM, Kim YM, Kwon YG, Park YS, Choi EY, Kim KW.

Oncol Rep. 2004 Jan;11(1):191-5.PMID: 14654925 [PubMed - indexed for MEDLINE]Related citations

Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo.

Cattaneo MG, Pola S, Francescato P, Chillemi F, Vicentini LM.

Exp Cell Res. 2003 Feb 15;283(2):230-6.PMID: 12581742 [PubMed - indexed for MEDLINE]Related citations

E-selectin is required for the antiangiogenic activity of endostatin.

Yu Y, Moulton KS, Khan MK, Vineberg S, Boye E, Davis VM, O'Donnell PE, Bischoff J, Milstone DS.

Proc Natl Acad Sci U S A. 2004 May 25;101(21):8005-10. Epub 2004 May 17.PMID: 15148373 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Assessment of antiangiogenic effect using 99mTc-EC-endostatin.

Yang DJ, Kim KD, Schechter NR, Yu DF, Wu P, Azhdarinia A, Roach JS, Kalimi SK, Ozaki K, Fogler WE, Bryant JL, Herbst R, Abbruzzes J, Kim EE, Podoloff DA.

Cancer Biother Radiopharm. 2002 Apr;17(2):233-45.PMID: 12030117 [PubMed - indexed for MEDLINE]Related citations